RICHMOND, Va., January 14, 2026 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced a major advancement in AI-driven Active ...

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...

Sustainability of small-molecule API manufacturing ensures continued success. Improving the sustainability of small-molecule API manufacturing is essential to ensuring the continued success of the ...

Sustainability advances are being made, but more investment is needed. When synthetic organic chemistry transformations were first developed, chemists did not take into consideration their impact on ...

Strong R&D investment, advanced manufacturing technologies, and supportive government policies accelerate global API production growth.Austin, Texas, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Small Molecule ...

The Active Pharmaceutical Ingredients (API) Market plays a crucial role in the pharmaceutical industry, forming the backbone of drug development and production. APIs are the biologically active ...

Process development is the exercise of creating new and improved manufacturing methods, optimizing them in terms of time and financial efficiency while maintaining regulatory compliance and product ...

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

Active Pharmaceutical Ingredients (APIs) are the biologically active components in pharmaceutical drugs that are responsible for the therapeutic effects. In simple terms, APIs are the key ingredient ...